These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3989 related articles for article (PubMed ID: 7108230)

  • 1. Position-dependent cell survival and the microcytotoxicity assay.
    Chalmers PJ; Pullen GR; Nind AP; Nairn RC
    J Immunol Methods; 1982; 51(1):81-8. PubMed ID: 7108230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-mediated cytotoxicity for melanoma tumor cells: detection by a (3H) proline release assay.
    Saal JG; Rieber EP; Riethmüller G
    Scand J Immunol; 1976; 5(5):455-66. PubMed ID: 959779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of experiments using the microcytotoxicity assay.
    Brown JP; van Belle G; Hellström I
    Int J Cancer; 1976 Aug; 18(2):230-5. PubMed ID: 955741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Problems in the clinical use of the microcytotoxicity assay for measuring cell-mediated immunity to tumor cells.
    Heppner G; Henry E; Stolbach L; Cummings F; McDonough E; Calabresi P
    Cancer Res; 1975 Aug; 35(8):1931-7. PubMed ID: 1149017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of strain specific typing antisera for genetic monitoring of inbred strains of rats.
    Kendall C; Wagner JE
    Lab Anim Sci; 1985 Aug; 35(4):364-9. PubMed ID: 4046546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new micromethod for the detection of HL-A antigens on cultured human tumor cells.
    Fritze D; Kern DH; Drogemuller CR; Pilch YH
    Transplantation; 1975 Sep; 20(3):211-8. PubMed ID: 125940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of a modified plate method for determining antibody-dependent cell-mediated cytotoxicity].
    Koĭchev Ch; Mikhaĭlova S; Gencheva G; Ivanova L; Grigorova K
    Eksp Med Morfol; 1983; 22(3):49-52. PubMed ID: 6671451
    [No Abstract]   [Full Text] [Related]  

  • 8. Lymphocyte mediated reactivity against malignant melanoma detected by a microcytotoxicity assay employing technetium-99m labeled target cells.
    Gillespie GY; Barth RF
    Cancer; 1978 Jun; 41(6):2174-82. PubMed ID: 350374
    [No Abstract]   [Full Text] [Related]  

  • 9. A long-term 51chromium assay for in vitro cell-mediated tumor immunity. Correlation with simultaneously performed microplate assays.
    Steele G; Sjögren HO; Lannerstad O; Stadenberg I
    Int J Cancer; 1975 Oct; 16(4):682-93. PubMed ID: 1176212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in sensitivity of the microcytotoxicity assay by T cell growth factor (IL-2)-containing preparations.
    Indrová M; Bubeník J
    Folia Biol (Praha); 1984; 30(1):43-9. PubMed ID: 6609090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of lymphocyte cytotoxicity for human colon carcinoma by treatment with solubilized tumour membrane fractions.
    Baldwin RW; Embleton MJ; Price MR
    Int J Cancer; 1973 Jul; 12(1):84-92. PubMed ID: 4790711
    [No Abstract]   [Full Text] [Related]  

  • 12. Variables and specificity of in vitro lymphocyte-mediated cytotoxicity in human melanoma.
    Mukherji B; Vassos D; Flowers A; Binder SC; Nathanson L
    Cancer Res; 1975 Dec; 35(12):3721-30. PubMed ID: 1192430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 51Cr release and microcytotoxicity assays against human melanoma cells.
    Hersey P; Edwards J; Edwards A; Adams E; Kearney R; Milton GW
    Int J Cancer; 1975 Jul; 16(1):164-72. PubMed ID: 1080748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro induction of tumour-specific immunity. I. Development of optimal conditions for induction and assay of cytotoxic lymphocytes.
    Burton R; Thompson J; Warner NL
    J Immunol Methods; 1975; 8(1-2):133-49. PubMed ID: 807654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic variations in cell-mediated immunity to skin allografts detected by the technetium-99m microcytotoxicity assay.
    Gillespie GY; Barth RF
    Cell Immunol; 1974 Sep; 13(3):472-83. PubMed ID: 4615818
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of sensitive complement-dependent microcytotoxicity serological methods.
    Richiardi P; Belvedere M; Borelli I; Curtoni ES
    Haematologica; 1977 Oct; 62(5):479-89. PubMed ID: 412735
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the microcytotoxicity test. I. Evidence that the effects of normal lymphoid cells on tumour cell growth in microtest plates may be caused by non-immunological modifications of the culture medium.
    Brooks CG; Rees RC; Baldwin RW
    Int J Cancer; 1976 Dec; 18(6):778-86. PubMed ID: 186418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A lymphocytotoxicity assay not requiring the in vitro culture of target tumor cells.
    Kreider JW; Flickinger JT; Lengle N; Shoff W
    Transplantation; 1974 Sep; 18(3):223-8. PubMed ID: 4422190
    [No Abstract]   [Full Text] [Related]  

  • 19. Lymphocyte anergy in patients with carcinoma.
    Nind AP; Nairn RC; Rolland JM; Guli EP; Hughes ES
    Br J Cancer; 1973 Aug; 28(2):108-17. PubMed ID: 4581078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of tumour associated antigens on human colonic carcinomata.
    Embleton MJ
    Br J Cancer Suppl; 1973 Aug; 1():142-52. PubMed ID: 4804277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 200.